Biontech provides update on plans to develop sustainable solutions to address infectious diseases on the african continent

Mainz, germany, july 26, 2021 (globe newswire) – biontech se (nasdaq: bntx, “biontech”) today announced the launch of its malaria project, which aims to develop a well-tolerated and highly effective malaria vaccine and implement sustainable vaccine supply solutions on the african continent.
BNTX Ratings Summary
BNTX Quant Ranking